Depression News and Research

Latest Depression News and Research

Promising results for new depression treatment

A new, non-invasive treatment for depression that delivers barely perceptible electric currents to the scalp has had promising results in a Sydney trial, and researchers are now looking for participants for a follow up study.

4 Apr 2011

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.

4 Apr 2011

Abbott and Enanta's ABT-450/r Phase 2 study results against HCV presented at EASL meeting

Abbott and Enanta Pharmaceuticals today announced 12-week results from a Phase 2 study of ABT-450/r, an investigational, oral protease inhibitor being developed for the treatment of hepatitis C infection.

4 Apr 2011

Researchers pinpoint effects of enhanced adult neurogenesis in hippocampus

Adult mice engineered to have more newborn neurons in their brain memory hub excelled at accurately discriminating between similar experiences - an ability that declines with normal aging and in some anxiety disorders.

4 Apr 2011

BMY announces PEG-Interferon lambda plus ribavirin Phase IIb trial results against HCV

Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.

4 Apr 2011

Researchers develop new way to stimulate neuron production in adult brain

Researchers at Columbia University Medical Center have developed a new way to stimulate neuron production in the adult mouse brain, demonstrating that neurons acquired in the brain's hippocampus during adulthood improve certain cognitive functions.

4 Apr 2011

Study: Antidepressants can thicken arteries and lead to heart disease

Antidepressant use has been linked to thicker arteries, possibly contributing to the risk of heart disease and stroke, in a study of twin veterans. The data is being presented Tuesday, April 5 at the American College of Cardiology meeting in New Orleans.

4 Apr 2011

Antidepressants may increase heart attack or stroke risk in men: Study

...

3 Apr 2011

PDHI adds Risky Drinking and Depression health action plan to its online library

Protocol Driven Healthcare, Inc. has added Risky Drinking and Depression to its online health action plan library, a component of the ConXus Steps product.

2 Apr 2011

New study examines psychological, social challenges of women with breast cancer

When an aggressive form of breast cancer strikes a young woman, what kind of stress, anxiety and other psychological and social challenges does she face?

1 Apr 2011

Study: Internet-based intervention can improve childhood sleep problems

A study in the April 1 issue of the journal SLEEP demonstrates that an Internet-based intervention was effective at reducing infant and toddler sleep disturbances, as well as providing positive, indirect benefits for maternal sleep, mood and confidence.

1 Apr 2011

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

A study in the April 1 issue of the journal SLEEP suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

1 Apr 2011

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease inhibitor VICTRELIS to peginterferon alfa-2b and ribavirin in adult patients with chronic hepatitis C virus genotype 1 infection.

1 Apr 2011

Post-sex blues in nearly 10% of women: Study

A new study suggests that many women do feel depressed after sex. The study involved more than 200 young Australian women who were questioned about their sex lives. At least one in three young women said they experienced post-coital blues at some point in their lives. Ten per cent said they frequently or almost always felt sad after making love. The study was published in the quarterly International Journal of Sexual Health.

31 Mar 2011

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Vanda Pharmaceuticals Inc. today announced its plans to initiate a Phase IIb/III clinical trial of tasimelteon in patients with Major Depressive Disorder (MDD). The trial is expected to begin during the second half of 2011. Tasimelteon is currently being evaluated in Phase III clinical trials for the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals without light perception.

31 Mar 2011

Researchers suggest link between dopamine-related genes and person's risk of addiction

There is growing evidence that the risk factors for addiction change throughout the lifespan. The risk factors for developing addiction in adolescence are the most intensively studied because this life phase is associated with the highest addiction risk.

31 Mar 2011

Basic Yellow 1 dye extends lifespan in healthy nematodes, slows Alzheimer's disease-like pathology in worms

Basic Yellow 1, a dye used in neuroscience laboratories around the world to detect damaged protein in Alzheimer's disease, is a wonder drug for nematode worms. In a study appearing in the March 30, online edition of Nature, the dye, also known as Thioflavin T, (ThT) extended lifespan in healthy nematode worms by more than 50 percent and slowed the disease process in worms bred to mimic aspects of Alzheimer's.

31 Mar 2011

Coro Health earns ALFA recognition for senior care programs

Coro Health, LLC, a provider of technology-based wellness therapies designed to improve the quality of life for seniors and caregivers, today announced it has been recognized as Program to Watch by the Assisted Living Federation of America 2011 Best of the Best Awards program.

31 Mar 2011

Facebook depression - a new diagnostic entity

A new study that appears in the April issue of the journal Pediatrics, published by the American Academy of Pediatrics, speaks of a “new phenomenon” known as “Facebook depression” in which children can become depressed when they compare such metrics as their number of “friends” and “status updates” to those of their peers.

30 Mar 2011

Maternal childhood maltreatment can affect offspring's health

Mothers who were maltreated as children have increased risk for giving birth to low birth weight babies. The findings, by researchers at the University of Washington, are the first to show that maternal maltreatment can affect the health of offspring.

30 Mar 2011

Depression News and Research

Latest Depression News and Research

Promising results for new depression treatment

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Abbott and Enanta's ABT-450/r Phase 2 study results against HCV presented at EASL meeting

Researchers pinpoint effects of enhanced adult neurogenesis in hippocampus

BMY announces PEG-Interferon lambda plus ribavirin Phase IIb trial results against HCV

Researchers develop new way to stimulate neuron production in adult brain

Study: Antidepressants can thicken arteries and lead to heart disease

Antidepressants may increase heart attack or stroke risk in men: Study

PDHI adds Risky Drinking and Depression health action plan to its online library

New study examines psychological, social challenges of women with breast cancer

Study: Internet-based intervention can improve childhood sleep problems

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Post-sex blues in nearly 10% of women: Study

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Researchers suggest link between dopamine-related genes and person's risk of addiction

Basic Yellow 1 dye extends lifespan in healthy nematodes, slows Alzheimer's disease-like pathology in worms

Coro Health earns ALFA recognition for senior care programs

Facebook depression - a new diagnostic entity

Maternal childhood maltreatment can affect offspring's health

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in